Profile data is unavailable for this security.
About the company
Bioton SA is a Poland-based company active in the pharmaceutical sector. The Company is engaged in research, development and wholesale trade of pharmaceutical and biotechnological products. The Company's portfolio consists of oral hypoglycemic drugs (metformin and glimepride) as well as recombinant human insulin in pharmaceutical substance form and for injections. Additionally, the Company provides advertising services. As of December 31, 2011, the Company formed a capital group and operated through its subsidiaries, including BIOTON TRADE Sp. z o.o., Mindar Holdings Ltd, Germonta Holdings Ltd, Tricel SA, SciGen Ltd and BioPartners Holdings AG, among others. On June 12, 2014, it sold a 50% stake in Copernicus Sp. z o.o.
- Revenue in PLN (TTM)186.32m
- Net income in PLN-6.85m
- Incorporated2004
- Employees358.00
- LocationBioton SAul. Staroscinska 5WARSZAWA 02-516PolandPOL
- Phone+48 227214000
- Fax+48 227211333
- Websitehttps://bioton.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Read Gene SA | 11.63m | -1.00m | 69.09m | 11.00 | -- | 37.03 | -- | 5.94 | -0.1084 | -0.1084 | 1.16 | 0.1583 | 0.9731 | 51.32 | 18.69 | -- | -8.40 | -1.06 | -8.56 | -1.31 | 92.67 | 88.41 | -8.63 | -2.42 | 23.52 | -2.46 | 0.00 | -- | 40.14 | 16.00 | -731.53 | -- | -- | -- |
| Pure Biologics SA | 69.00k | -33.63m | 81.24m | 29.00 | -- | -- | -- | 1,177.38 | -10.40 | -10.40 | 0.0213 | -0.9246 | 0.0015 | -- | 0.2075 | 1,352.94 | -72.94 | -65.91 | -99.86 | -109.50 | -2,439.13 | 6.97 | -48,734.78 | -487.38 | -- | -8.41 | 1.30 | -- | -85.65 | -60.22 | -39.41 | -- | 1.65 | -- |
| Sds Optic SA | 370.00 | -8.98m | 82.87m | -- | -- | -- | -- | 223,982.30 | -1.52 | -1.52 | 0.00006 | -0.0545 | 0.00003 | 65.75 | 0.0006 | -- | -74.69 | -- | -86.32 | -- | -371,002.80 | -- | -2,452,795.00 | -- | 9.61 | -47.49 | -- | -- | -99.61 | -- | -85.09 | -- | -- | -- |
| Genomtec SA | -89.00k | -9.59m | 98.06m | -- | -- | 17.37 | -- | -- | -0.8159 | -0.8159 | -0.0076 | 0.4604 | -0.0064 | 27.93 | -- | -- | -68.62 | -- | -107.95 | -- | -- | -- | -- | -- | 1.12 | -58.91 | 0.2064 | -- | -97.50 | -- | 24.44 | -- | -- | -- |
| Nanogroup SA | -24.98k | -7.35m | 100.73m | -- | -- | 25.65 | -- | -- | -0.3477 | -0.3477 | -0.0012 | 0.1587 | -0.0016 | 7.38 | -- | -- | -47.32 | -23.18 | -59.79 | -26.06 | -- | -278.03 | -- | -1,567.57 | 0.4541 | -2,241.44 | 0.00 | -- | -98.55 | -55.07 | -840.84 | -- | -8.99 | -- |
| Urteste SA | 0.00 | -5.49m | 134.20m | -- | -- | 5.08 | -- | -- | -4.21 | -4.21 | 0.00 | 18.74 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 16.97 | -- | 0.0263 | -- | -100.00 | -- | -37.59 | -- | -- | -- |
| Molecure SA | 360.18k | -21.91m | 235.37m | 112.00 | -- | 2.50 | -- | 653.47 | -1.35 | -1.35 | 0.0223 | 5.59 | 0.003 | -- | 0.0741 | 3,244.87 | -18.17 | 2.64 | -19.29 | 2.76 | -444.01 | 97.54 | -6,082.40 | 12.84 | -- | -- | 0.0657 | -- | -18.85 | 237.24 | -19.67 | -- | -24.82 | -- |
| Poltreg SA | 600.00k | -17.42m | 254.62m | 23.00 | -- | 3.21 | -- | 424.37 | -3.74 | -3.74 | 0.1287 | 17.04 | 0.0051 | 27.12 | 3.22 | 26,373.63 | -14.82 | -6.51 | -16.41 | -7.35 | -1,804.83 | -391.38 | -2,903.50 | -449.24 | 4.21 | -- | 0.0913 | -- | 40.04 | -- | -588.92 | -- | 214.26 | -- |
| Mabion SA | 139.86m | 37.39m | 270.88m | 226.00 | 7.25 | 1.86 | 5.88 | 1.94 | 2.31 | 2.31 | 8.65 | 9.01 | 0.7538 | 4.02 | 17.35 | 618,836.30 | 20.15 | -7.19 | 25.09 | -16.79 | 78.30 | 58.10 | 26.73 | -14.27 | 1.64 | 101.63 | 0.026 | -- | -7.50 | -- | 77.94 | -- | 40.86 | -- |
| BIOTON SA | 186.32m | -6.85m | 290.22m | 358.00 | -- | 0.4849 | 11.26 | 1.56 | -0.0797 | -0.0797 | 2.17 | 6.97 | 0.2303 | 1.02 | 21.19 | 520,435.80 | -0.8464 | -1.99 | -1.04 | -2.47 | 33.80 | 45.33 | -3.67 | -8.61 | 0.2085 | 0.3295 | 0.0864 | -- | -22.10 | -5.51 | 60.10 | -38.69 | 0.3284 | -- |
| Captor Therapeutics SA | 18.64m | -46.69m | 345.98m | 104.00 | -- | 6.83 | -- | 18.56 | -10.29 | -10.29 | 4.08 | 10.87 | 0.2391 | -- | 5.26 | 179,230.80 | -59.88 | -- | -83.65 | -- | 51.97 | -- | -250.46 | -- | -- | -- | 0.1114 | -- | 44.15 | -- | -96.65 | -- | -- | -- |
| Scope Fluidics SA | 93.00k | -22.60m | 447.05m | 40.00 | -- | 6.03 | -- | 4,807.02 | -8.29 | -8.29 | 0.0341 | 27.18 | 0.0009 | 2.94 | 0.0337 | 2,325.00 | -21.76 | 52.74 | -22.74 | 57.32 | -2,022.58 | -420.87 | -24,304.30 | 30,134.78 | 13.86 | -- | 0.0299 | -- | 27.72 | -- | -105.76 | -- | 89.99 | -- |
| Selvita SA | 337.26m | 65.30m | 1.15bn | 387.00 | 17.68 | 3.53 | 10.24 | 3.42 | 3.56 | 3.56 | 18.37 | 17.83 | 0.553 | 9.29 | 4.70 | 398,178.30 | 10.71 | -- | 12.99 | -- | 79.66 | -- | 19.36 | -- | 1.41 | 11.34 | 0.4063 | -- | -3.48 | -- | 130.55 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to Bioton SA's reporting currency: Polish New Zloty PLN
0.44%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 31 May 2024 | 237.78k | 0.28% |
| Polunin Capital Partners Ltd.as of 30 Jun 2024 | 106.49k | 0.12% |
| Dimensional Fund Advisors Ltd.as of 31 May 2024 | 26.92k | 0.03% |
| DFA Australia Ltd.as of 31 Jul 2024 | 1.68k | 0.00% |
| SSgA Funds Management, Inc.as of 05 Sep 2024 | 1.11k | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
